First Evidence of the Liposome-Mediated Deintercalation of Anticancer Drug Doxorubicin from the Drug-DNA Complex : A Spectroscopic Approach

Biocompatible liposomes were used for the first time to study the deintercalation process of a prominent anticancer drug, doxorubicin (DOX), from doxorubicin-intercalated DNA (DOX-DNA complex) under controlled experimental conditions. The study revealed that anionic liposomes (DMPG liposomes) appear...

Description complète

Détails bibliographiques

Publié dans:	Langmuir : the ACS journal of surfaces and colloids. - 1985. - 32(2016), 1 vom: 12. Jan., Seite 159-70
Auteur principal:	Das, Anupam (Auteur)
Autres auteurs:	Adhikari, Chandan, Nayak, Debasis, Chakraborty, Anjan
Format:	Article en ligne
Langue:	English
Publié:	2016
Accès à la collection:	Langmuir : the ACS journal of surfaces and colloids
Sujets:	Journal Article Research Support, Non-U.S. Gov't Antineoplastic Agents DNA Adducts Liposomes doxorubicin-DNA Doxorubicin 80168379AG